GlassScriptPhysician profile
Joseph Sean Womack
NPI 1003816901
$1,712.80
in general payments reported to CMS, 2019-2025
25 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $99.62 · 2021: $152 · 2022: $207 · 2023: $387 · 2024: $339 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $225.08 | 2019-2024 | Myrbetriq, Veozah |
| Abbvie INC. | $191.55 | 2019-2024 | Botox |
| Teleflex LLC | $187.27 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $183.80 | 2019-2024 | Rezum Generator, Spaceoar System |
| Axonics, INC. | $121.69 | 2022-2024 | Axonics, Bulkamid |
| Calyxo, INC. | $108.22 | 2025 | Cvac Aspiration System |
| Neotract INC. | $103.88 | 2019-2020 | |
| Accord Healthcare, INC. | $68.66 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $66.40 | 2019-2024 | Adstiladrin |
| Procept Biorobotics Corporation | $64.68 | 2021-2024 | Aquabeam Robotic System, Aquabeam System |
| Sumitomo Pharma America, INC. | $53.81 | 2024 | Gemtesa |
| Blue Earth Diagnostics | $48.47 | 2019-2021 | |
| Urovant Sciences INC | $47.08 | 2022 | |
| Medtronic, INC. | $46.55 | 2023-2024 | Interstim |
| Ambu INC. | $25.25 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $23.93 | 2024 | Self-Cath |
| Pfizer INC. | $19.62 | 2023 | |
| Allergan, INC. | $18.74 | 2021 | |
| Merck Sharp & Dohme LLC | $18.08 | 2021 | |
| Siemens Medical Solutions USA, INC. | $17.51 | 2019 | |
| Biocompatibles, INC. | $17.09 | 2019 | |
| Cook Medical LLC | $15.10 | 2022 | |
| Urogen Pharma, INC. | $14.66 | 2023 | Jelmyto |
| Tolmar, INC. | $14.45 | 2024 | |
| Coloplast Corp | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Womack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.